🔬 LATEST HEALTH NEWS: New study highlights benefits of targeted prebiotic fiber on gut barrier integrity • Vitamin D3 & K2 synergy guidelines updated for seasonal metabolic resilience • Human clinical trial updates on Berberine and GLP-1 pathways.
MIK NOVA INSIGHTS
Bioactive Pharmacopeia

Clinical Monographs

Unbranded, evidence-based compendial dossiers covering bioactive molecule specifications, purity assays, and clinical human trial data.

USP COMPENDIAL Assay Purity: ≥98.5%

Magnesium Bisglycinate Chelate 200mg

Fully reacted, highly bioavailable chelated mineral bound to two glycine molecules. Enhanced intestinal peptide transit with zero osmotic diarrhea risk.

Non-GMO Vegan HPMC Heavy-Metal Audited
5 Human Trials (n=482) View Full Monograph →
CLINICAL DOSSIER Viability: 50B CFU Verified

Targeted Probiotic & Astragalus Polysaccharide

Four-strain acid-resistant microbial consortium shielded by prebiotic botanical scaffolding for documented lower-ileum survival and mucosal colonisation.

ST81 / BL21 / BBi32 / LRa66 Delayed-Release Shell
9 Clinical Studies Cited View Full Monograph →